STOCK TITAN

Ashland reports preliminary financial results for first quarter of fiscal year 2021

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary

Ashland Global Holdings Inc. (NYSE: ASH) reported preliminary financial results for Q1 FY2021, with sales reaching $552 million, up 4% year-over-year. The net income stood at $56 million or $0.91 per diluted share, significantly higher than $32 million last year. Income from continuing operations was $61 million or $0.99 per diluted share. Adjusted EBITDA rose to $124 million from $88 million the previous year. Operating cash flows were $106 million, improving from a deficit of $34 million in the prior-year quarter.

Positive
  • Sales increased by 4% year-over-year to $552 million.
  • Net income improved to $56 million from $32 million last year.
  • Income from continuing operations rose to $61 million compared to $34 million the previous year.
  • Adjusted EBITDA increased to $124 million from $88 million in the prior year.
  • Free cash flow improved to $76 million from a deficit of $63 million last year.
Negative
  • None.
  • Sales of $552 million, up four percent from the prior-year quarter
  • Net income of $56 million, or $0.91 per diluted share
  • Income from continuing operations of $61 million, or $0.99 per diluted share
  • Adjusted income from continuing operations excluding intangibles amortization expense of $58 million, or $0.94 per diluted share
  • Adjusted EBITDA of $124 million
  • Cash flows provided by operating activities of $106 million; free cash flows of $76 million

WILMINGTON, Del., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Ashland Global Holdings Inc. (NYSE: ASH) today announced preliminary1 financial results for the first quarter of fiscal year 2021, which ended December 31, 2020. The global specialty materials company serves customers in a wide range of consumer and industrial markets.

Ashland’s financial results during the quarter reflected execution of the company’s strategy, solid overall demand and the benefit of continued cost reduction. The result was improved sales and earnings, margin growth and strong free cash flow generation. Sales were approximately $552 million, up four percent compared to the prior-year period, as growth was realized in all three of Ashland’s business groups.

Net income was $56 million compared to net income of $32 million in the prior-year quarter. Income from continuing operations was $61 million compared to income of $34 million in the prior-year quarter, or $0.99 per diluted share compared to $0.56 in the prior-year quarter. Adjusted income from continuing operations excluding intangibles amortization expense was $58 million compared to $25 million in the prior-year quarter, or $0.94 per diluted share, up from $0.41 in the prior-year quarter. Adjusted EBITDA was $124 million, up from $88 million in the prior-year quarter, driven primarily by lower operating expenses, favorable mix, improved sales in all three business groups and lower selling, general, administrative and research and development (“SARD”) expenses.

Cash flows provided by operating activities totaled $106 million compared to a deficit of $34 million in the prior-year quarter. Free cash flows totaled $76 million compared to a deficit of $63 million in the prior-year quarter, driven primarily by increased earnings and disciplined working capital management.

“Ashland’s financial results in the first quarter reflect our progress toward demonstrating strategic discipline, consistent organic growth, margin expansion and improved free cash flow conversion,” said Guillermo Novo, chairman and chief executive officer, Ashland. “Our industrial businesses continue to see strong demand recovery, and excluding specific mix actions, our core consumer businesses continue to demonstrate top-line resilience and growth. All business groups expanded margins compared to the prior-year period. Also, Ashland’s free cash flow improved dramatically when compared to the prior year, reflecting the broad-based efforts by our teams to grow earnings and continue to improve working capital.”

“I am pleased with the progress our team has made driving more consistent performance while delivering profitable growth and improved cash generation,” continued Novo. “While the uncertainty related to the COVID-19 pandemic continues to impact global supply chains and consumer behavior, the continued progress made by our teams in the first-fiscal quarter gives me even more confidence in our ability to deliver consistent results. I look forward to sharing additional thoughts on our plans and the progress we have made during our earnings call tomorrow morning.”

Reportable Segment Performance
To aid in the understanding of Ashland’s ongoing business performance, the results of Ashland’s reportable segments are described below on an adjusted basis. In addition, EBITDA and adjusted EBITDA are reconciled to operating income in Table 4. Free cash flow and adjusted operating income are reconciled in Table 6 and adjusted income from continuing operations, adjusted diluted earnings per share and adjusted diluted earnings per share excluding intangible amortization expense are reconciled in Table 7 of this news release. These adjusted results are considered non-GAAP financial measures.  For a full description of the non-GAAP financial measures used, see the “Use of Non-GAAP Measures” section that further describes these adjustments below.

Consumer Specialties

Sales were $296 million, up one percent from the prior-year quarter. Foreign currency favorably impacted sales by two percent. Strong demand in most consumer end markets was nearly offset by our exit from lower-margin product lines and continued Avoca challenges, both within Personal Care and Household.

Operating income was $44 million, compared to $33 million in the prior-year quarter. Adjusted EBITDA was $79 million, up 18% from the prior-year quarter, reflecting favorable mix and lower SARD expenses in both the Life Sciences and Personal Care and Household segments.

Industrial Specialties

Sales were $231 million, up eight percent from the prior-year quarter, driven by improving global demand for architectural coatings, construction and adhesive applications. Foreign currency favorably impacted sales by two percent.

Operating income was $22 million, compared to $19 million in the prior-year quarter. Adjusted EBITDA was $55 million, up 28% from the prior-year quarter, driven by favorable volumes, mix and SARD expenses.

Intermediates & Solvents

Sales were $33 million, up 18% from the prior-year quarter, primarily reflecting normalized internal sales volumes versus prior year when there was a planned extended shutdown at the Lima, Ohio facility.

Operating income was $2 million, up from an operating loss of $12 million in the prior-year quarter. Adjusted EBITDA was $5 million, up from negative $9 million in the prior-year quarter, which included the impact of the shutdown at the Lima facility.

Unallocated & Other

Unallocated and Other expense was $27 million, compared to $23 million in the prior-year quarter, primarily due to higher restructuring-related expenses. Adjusted Unallocated and Other expense was $15 million, compared to an expense of $16 million in the prior-year quarter.

Conference Call Webcast
Ashland will host a live webcast of its first-quarter conference call with securities analysts at 9:00 a.m. ET Thursday, February 4, 2021. The webcast will be accessible through Ashland’s website at http://investor.ashland.com and will include a slide presentation. Following the live event, an archived version of the webcast and supporting materials will be available for 12 months.

Use of Non-GAAP Measures
Ashland believes that by removing the impact of depreciation and amortization and excluding certain non-cash charges, amounts spent on interest and taxes and certain other charges that are highly variable from year to year, EBITDA, adjusted EBITDA, EBITDA margin and adjusted EBITDA margin provide Ashland’s investors with performance measures that reflect the impact to operations from trends in changes in sales, margin and operating expenses, providing a perspective not immediately apparent from net income, operating income, net income margin and operating income margin. The adjustments Ashland makes to derive the non-GAAP measures of EBITDA, adjusted EBITDA, EBITDA margin and adjusted EBITDA margin exclude items which may cause short-term fluctuations in net income and operating income and which Ashland does not consider to be the fundamental attributes or primary drivers of its business. EBITDA, adjusted EBITDA, EBITDA margin and adjusted EBITDA margin provide disclosure on the same basis as that used by Ashland’s management to evaluate financial performance on a consolidated and reportable segment basis and provide consistency in our financial reporting, facilitate internal and external comparisons of Ashland’s historical operating performance and its business units and provide continuity to investors for comparability purposes. EBITDA margin and adjusted EBITDA margin are defined as EBITDA and adjusted EBITDA divided by sales for the corresponding period.

Key items, which are set forth on Table 7 of this release, are defined as financial effects from significant transactions that, either by their nature or amount, have caused short-term fluctuations in net income and/or operating income which Ashland does not consider to most accurately reflect Ashland’s underlying business performance and trends.  Further, Ashland believes that providing supplemental information that excludes the financial effects of these items in the financial results will enhance the investor’s ability to compare financial performance between reporting periods.

Tax-specific key items, which are set forth on Table 7 of this release, are defined as financial transactions, tax law changes or other matters that fall within the definition of key items as described above.  These items relate solely to tax matters and would only be recorded within the income tax caption of the Statement of Consolidated Income.  As with all key items, due to their nature, Ashland does not consider the financial effects of these tax-specific key items on net income to be the most accurate reflection of Ashland’s underlying business performance and trends.

The free cash flow metric enables Ashland to provide a better indication of the ongoing cash being generated that is ultimately available for both debt and equity holders as well as other investment opportunities. Unlike cash flow provided by operating activities, free cash flow includes the impact of capital expenditures from continuing operations, providing a more complete picture of cash generation. Free cash flow has certain limitations, including that it does not reflect adjustment for certain non-discretionary cash flows such as mandatory debt repayments. The amount of mandatory versus discretionary expenditures can vary significantly between periods.

Adjusted diluted earnings per share is a performance measure used by Ashland and is defined by Ashland as earnings (loss) from continuing operations, adjusted for identified key items and divided by the number of outstanding diluted shares of common stock.  Ashland believes this measure provides investors additional insights into operational performance by providing earnings and diluted earnings per share metrics that exclude the effect of the identified key items and tax specific key items.

Adjusted diluted earnings per share, excluding intangibles amortization expense metric enables Ashland to demonstrate the impact of non-cash intangibles amortization expense on earnings per share, in addition to key items previously mentioned. Ashland’s management believes this presentation is helpful to illustrate how previous acquisitions impact applicable period results.

About Ashland 
Ashland Global Holdings Inc. (NYSE: ASH) is a premier specialty materials company with a conscious and proactive mindset for sustainability. The company serves customers in a wide range of consumer and industrial markets, including adhesives, architectural coatings, automotive, construction, energy, food and beverage, nutraceuticals, personal care and pharmaceutical. Approximately 4,200 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries. Visit ashland.com and ashland.com/sustainability to learn more. 

Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Ashland has identified some of these forward-looking statements with words such as “anticipates,” “believes,” “expects,” “estimates,” “is likely,” “predicts,” “projects,” “forecasts,” “objectives,” “may,” “will,” “should,” “plans” and “intends” and the negative of these words or other comparable terminology. Ashland may from time to time make forward-looking statements in its annual reports, quarterly reports and other filings with the SEC, news releases and other written and oral communications. These forward-looking statements are based on Ashland’s expectations and assumptions, as of the date such statements are made, regarding Ashland’s future operating performance, financial condition, and expected effects of the COVID-19 pandemic on Ashland’s business, as well as the economy and other future events or circumstances. These statements include but may not be limited to Ashland’s expectations regarding its ability to drive sales and earnings growth and realize further cost reductions.

Ashland’s expectations and assumptions include, without limitation, internal forecasts and analyses of current and future market conditions and trends, management plans and strategies, operating efficiencies and economic conditions (such as prices, supply and demand, cost of raw materials, and the ability to recover raw-material cost increases through price increases), and risks and uncertainties associated with the following: the impact of acquisitions and/or divestitures Ashland has made or may make (including the possibility that Ashland may not realize the anticipated benefits from such transactions); Ashland’s substantial indebtedness (including the possibility that such indebtedness and related restrictive covenants may adversely affect Ashland’s future cash flows, results of operations, financial condition and its ability to repay debt); severe weather, natural disasters, public-health crises (including the current COVID-19 pandemic), cyber events and legal proceedings and claims (including product recalls, environmental and asbestos matters); the effects of the COVID-19 pandemic on the geographies in which we operate, the end markets we serve and on our supply chain and customers, and without limitation, risks and uncertainties affecting Ashland that are described in Ashland’s most recent Form 10-K (including Item 1A Risk Factors) filed with the SEC, which is available on Ashland’s website at http://investor.ashland.com or on the SEC’s website at http://www.sec.gov. Various risks and uncertainties may cause actual results to differ materially from those stated, projected or implied by any forward-looking statements. The extent and duration of the COVID-19 pandemic on our business and operations is uncertain. Factors that will influence the impact on our business and operations include the duration and extent of the pandemic, the extent of imposed or recommended containment and mitigation measures, and the general economic consequences of the pandemic. Ashland believes its expectations and assumptions are reasonable, but there can be no assurance that the expectations reflected herein will be achieved. Unless legally required, Ashland undertakes no obligation to update any forward-looking statements made in this news release whether as a result of new information, future events or otherwise.

1Financial results are preliminary until Ashland’s Form 10-Q is filed with the SEC

™ Trademark, Ashland or its subsidiaries, registered in various countries.

FOR FURTHER INFORMATION:

Investor Relations:                                                     Media Relations:
Seth A. Mrozek                                                          Carolmarie C. Brown
+1 (302) 594-5010                                                      +1 (302) 995-3158
samrozek@ashland.com                                         ccbrown@ashland.com


Attachments


FAQ

What were Ashland's Q1 FY2021 sales figures?

Ashland reported sales of $552 million for Q1 FY2021, a 4% increase from the previous year.

How much did Ashland earn per share in Q1 FY2021?

Ashland's net income for Q1 FY2021 was $56 million, or $0.91 per diluted share.

What was the adjusted EBITDA for Ashland in Q1 FY2021?

Ashland's adjusted EBITDA for Q1 FY2021 was $124 million, up from $88 million in the same quarter last year.

How did Ashland's cash flow perform in Q1 FY2021?

Ashland generated $106 million in operating cash flows and $76 million in free cash flows in Q1 FY2021.

Ashland Inc.

NYSE:ASH

ASH Rankings

ASH Latest News

ASH Stock Data

3.38B
46.67M
1.04%
96.32%
2.25%
Specialty Chemicals
Wholesale-chemicals & Allied Products
Link
United States of America
WILMINGTON